Group 1 - The controlling shareholder, Jiulongjiang Group, plans to increase its stake in the company by investing between RMB 300 million and RMB 500 million from February 1, 2026, to July 31, 2026, using its own and raised funds through the Shanghai Stock Exchange [1][2] - Jiulongjiang Group has received a loan commitment from the Industrial and Commercial Bank of China, Zhangzhou Branch, for a maximum amount of RMB 450 million to support the share purchase, with a loan term of three years [2] - The remaining funds for the share purchase will come from Jiulongjiang Group's own resources, indicating confidence in the company's long-term investment value [1][2] Group 2 - The company will continue to monitor the progress of the share purchase plan and fulfill its information disclosure obligations to investors [2] - The announcement emphasizes that the board guarantees the accuracy and completeness of the information provided [1] - The company acknowledges potential risks that may affect the implementation of the share purchase plan due to changes in the capital market [2]

Core Viewpoint - The announcement details the progress of a share buyback plan by the company and its major shareholders, reflecting confidence in the company's long-term investment value and strategic development plans [2][5]. Group 1: Buyback Plan Details - The buyback plan was initially disclosed on January 14, 2026, with a total intended investment between RMB 14.5 million and RMB 16.4 million [2][5]. - The buyback is being executed by 22 individuals, including directors and senior management from the company and its controlling shareholder, Beijing Automotive Group [5]. Group 2: Implementation Progress - As of January 29, 2026, the buyback has resulted in the acquisition of 1,331,000 shares, representing 0.02% of the total share capital, with a total investment of RMB 11.03 million, exceeding 50% of the minimum planned investment [3][6]. - The controlling shareholder and its concerted actions hold a total of 2,351,220,897 shares, accounting for 42.19% of the total share capital, and the buyback will not change the control of the company [6]. Group 3: Compliance and Commitments - The buyback complies with relevant laws and regulations, ensuring that it does not affect the company's listing conditions or change the controlling shareholder [8]. - The buyback participants have committed not to sell the acquired shares for six months following the completion of the buyback plan [8].

Group 1 - The core viewpoint of the article is that the company, Okeyi, expresses confidence in its future stable development and long-term investment value through its decision to increase shareholding [1] Group 2 - The company believes it possesses long-term investment value, which is a key reason for the increase in shareholding [1] - The response to investors indicates a positive outlook on the company's future performance [1]

Core Viewpoint - Tianli International Holdings (01773) announced that its executive director, chairman, and CEO, Mr. Luo, purchased a total of 300,000 ordinary shares in the open market on January 28, 2026, indicating confidence in the company's business outlook [1] Group 1: Share Purchase Details - Mr. Luo acquired 300,000 shares at an average price of approximately HKD 2.77 per share, representing about 0.01% of the company's total issued shares of 2.109 billion [1] - Following the purchase, Mr. Luo holds a total of 921.69 million shares, which constitutes approximately 44.05% of the company's issued shares as of the announcement date [1] - Mr. Luo has also been granted 30 million share options under the share option plan, which he has not exercised as of the announcement date [1] Group 2: Share Buyback Announcement - The company announced a share buyback of 200,000 shares on January 28, 2026, which represents about 0.0095% of the total issued shares [1] - The repurchased shares will be held as treasury shares by the company [1]

Core Viewpoint - The stock of Innovent Biologics-B (09939) has seen an increase of over 3%, currently trading at 3.01 HKD with a transaction volume of 8.0533 million HKD, following an announcement regarding share buyback by the company's chairman, Dr. Hui Zhi Tong [1] Group 1 - On January 26, Innovent Biologics-B announced that its board received notification from Dr. Hui Zhi Tong, the chairman, executive director, and CEO, regarding a share buyback plan [1] - Dr. Hui plans to acquire approximately 10.82 million HKD worth of shares through his wholly-owned company, KT International Investment Limited, in the open market, at an average price of 2.30 HKD per share, with a price range of 1.89 HKD to 2.81 HKD [1] - The buyback will involve 4.7 million shares, representing about 0.9425% of the total issued share capital as of the announcement date [1] Group 2 - Dr. Hui expressed confidence in the overall development prospects and commercialization transformation of the company [1] - He does not rule out the possibility of further increasing his stake in the company after the silent period, which ends on March 26, 2026 [1]

Group 1 - The company announced that its major shareholder, Lanzhou Asia-Pacific Mining Group Co., Ltd., has had its shares subject to a pending freeze [1][2] - The total number of shares held by Lanzhou Asia-Pacific Mining is 27,387,895, which represents a portion of the company's total share capital of 484,905,000 [1] - The company has not received any additional written documentation regarding the pending freeze apart from the data provided by the China Securities Depository and Clearing Corporation [2] Group 2 - The company disclosed a plan for its shareholder, Guangzhou Wanshun Technology Co., Ltd., and its concerted parties to increase their shareholding [5][6] - On January 26, 2026, Guangzhou Wanshun and its concerted parties signed a "Concerted Action Agreement" with a term of one year [8][9] - The plan includes acquiring between 4,800,000 and 9,600,000 shares through block trading over the next six months, starting from January 26, 2026 [23][29] Group 3 - Prior to the increase, Guangzhou Wanshun and its concerted parties held a total of 53,011,595 shares, accounting for 10.9324% of the company's total share capital [25] - The funding for the share acquisition will come from self-owned or self-raised funds, with no fixed price set for the shares [29][31] - The company will ensure compliance with relevant laws and regulations during the implementation of the share increase plan [34][35]

Core Viewpoint - Yunyi Electric has announced a share repurchase plan of 100 million to 150 million RMB to be used for employee stock ownership plans or equity incentives, alongside plans for major shareholders to increase their stakes in the company, despite the stock price being at a relatively high level and a slowdown in performance growth [1][2][4]. Group 1: Share Repurchase and Stake Increase - The company plans to repurchase shares using its own funds, with a total amount between 100 million and 150 million RMB, at a maximum price of 17 RMB per share [2]. - Based on the lower limit of 100 million RMB, the estimated number of shares to be repurchased is approximately 588,240 shares, representing 0.67% of the total share capital; at the upper limit of 150 million RMB, the estimated number is about 882,350 shares, or 1% of the total share capital [2]. - The actual controller, Fu Hongling, plans to increase her stake by 30 million to 60 million RMB, while the vice president, Zhang Jing, plans to increase her stake by 5 million to 10 million RMB within the next six months [2]. Group 2: Recent Performance and Growth - Yunyi Electric's stock price has risen significantly from a low of 6.10 RMB in April 2025 to a high of 15.63 RMB in September 2025, marking a maximum increase of 156.23% [3]. - As of the announcement date, the stock price was reported at 13.7 RMB per share, with a TTM price-to-earnings ratio of 28.3 [3]. - The company has experienced a slowdown in performance growth, with revenue for the first three quarters of 2025 reaching 1.666 billion RMB, a year-on-year increase of 7.05%, and net profit of 331 million RMB, a year-on-year increase of 7.80% [5]. Group 3: Business Expansion and Strategic Initiatives - Yunyi Electric is involved in the development, production, and sales of automotive intelligent core electronic products, with total assets of 4.566 billion RMB and a debt-to-asset ratio of 22.14% as of September 30, 2025 [4]. - The company has announced plans to establish a joint venture with Chenzhi Automotive Technology Group to create a comprehensive high-tech enterprise, with a registered capital of 402 million RMB and a 30% ownership stake [4]. - Additionally, the company is expanding into the robotics sector and plans to invest 100 million RMB to establish a wholly-owned subsidiary in Nanjing [4].

格隆汇1月22日丨云意电气(300304.SZ)公布，实际控制人、董事长兼总经理付红玲女士基于对公司未来 发展的信心和长期投资价值的认同，计划从本公告披露之日起6个月内，通过深圳证券交易所系统以集 中竞价交易方式增持公司股份，拟合计增持金额不低于人民币3,000万元且不高于人民币6,000万元，增 持所需的资金来源为自有或自筹资金。 ...

人民财讯1月22日电，云意电气（300304）1月22日公告，公司拟1亿元至1.5亿元回购公司股份用于实施 员工持股计划或股权激励，回购价格不超过17元/股。公司同日公告，公司实控人、董事长兼总经理付 红玲计划通过深交所以集中竞价交易方式增持公司股份，拟合计增持金额不低于3000万元且不高于6000 万元，公司董事兼副总经理张晶拟增持金额不低于500万元且不高于1000万元。 ...

（记者 王瀚黎） 每经AI快讯，云意电气1月22日晚间发布公告称，江苏云意电气股份有限公司董事兼副总经理张晶女士 基于对公司未来发展的信心和长期投资价值的认同，计划从本公告披露之日起6个月内，通过深圳证券 交易所系统以集中竞价交易方式增持公司股份，拟合计增持金额不低于人民币500万元且不高于人民币 1000万元，增持所需的资金来源为自有或自筹资金。截至本公告日，张晶女士未直接持有公司股份；其 持有公司控股股东徐州云意科技发展有限公司19.6%股权（徐州云意科技发展有限公司持有公司股份约 3.52亿股，占公司总股本的40.1%）。 每经头条（nbdtoutiao）——特朗普强要格陵兰岛，丹麦一养老基金率先清仓美债，美国资产全线下 跌！欧洲手握"金融核按钮"，双方会"鱼死网破"吗？专家解读→ ...